Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Avineuro commences phase I AVN-101 study for Alzheimer's disease

April 9, 2009

Novel inhibitors of Abeta calcium channel activity confer neuroprotection in vitro

April 9, 2009

Schering-Plough patent discloses novel gamma-secretase modulators for the treatment of AD

April 9, 2009

FDA Advisory Committee provides opinion on Serdolect in schizophrenia

April 8, 2009

Aplenzin extended-release tablets available in the U.S.

April 8, 2009

GSK researchers describe new histamine H3 receptor antagonists for cognitive impairment

April 8, 2009

Novel beta-secretase inhibitor shows activity in mouse model of Alzheimer's disease

April 7, 2009

Potassium channel modulators in early development at Valeant for the treatment of epilepsy

April 7, 2009

Roche describes novel TAAR1 ligands and their use as antidepressants

April 7, 2009

Orchid Research Laboratories presents novel monoamine oxidase inhibitors

April 6, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...